Skip to main
OGEN
OGEN logo

Oragenics (OGEN) Earnings Dates & Reports

Oragenics (OGEN) Most Recent Earnings

Report DateMay 12, 2023
Period EndingQ1 2023
Est. EPS-$3
Actual EPS-$1.41
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Oragenics (OGEN) Earnings per Share (EPS) History

Signup for full access
Browse free

Oragenics (OGEN) Latest Earnings

The value each OGEN share was expected to gain vs. the value each share gained.

Oragenics (OGEN) reported its most recent earnings on May 12, 2023 for Q1 2023, posting earnings per share (EPS) of -$1.41. This exceeded analysts' expectations of -$3 by 53.00%, marking a Beat.

For comparison, Oragenics reported EPS of -$3 in the same quarter last year.

The company is expected to announce its next earnings report on 08/08/2025, with analysts projecting an EPS of $0.

Oragenics (OGEN) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Aug 8, 2025
Next earnings call Aug. 8, 2025
Q1 2025May 9, 2025
-$0.12
DeckReportListen
Q4 2024Mar 14, 2025
-$0.11
Q3 2024Nov 13, 2024
-$0.38
Q2 2024Aug 9, 2024
-$0.51
View all

Oragenics (OGEN) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Oragenics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 9, 2025
Mar 14, 2025
Nov 13, 2024
Aug 9, 2024

Oragenics (OGEN) Earnings FAQs

Oragenics (OGEN) last reported earnings on May 12, 2023 for Q1 2023, posting an EPS of -$1.41, which Beat the estimate of -$3 by 53.00%.

For Q1 2023, Oragenics (OGEN) reported an EPS of -$1.41, exceeding analysts' estimate of -$3 by 53.00%.

For Q1 2023, Oragenics (OGEN) Beat expectations with an actual EPS of -$1.41 vs. an estimated EPS of -$3.

Following the last earnings report on May 12, 2023, Oragenics (OGEN)'s stock price moved — from — to —.

The next Oragenics (OGEN) earnings call is scheduled for Aug. 8, 2025, where executives will discuss financial results and outlook.

Oragenics (OGEN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.